Krystal Biotech (KRYS)
NASDAQ:KRYS

Krystal Biotech (KRYS) Financial Statements

427 Followers

Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $1.882; its P/E ratio is 110.07; Krystal Biotech is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 42.14M$ 8.60M---
Gross Profit$ 39.27M$ 8.60M---
EBIT$ 113.26M$ 74.50M$ -38.05M$ -48.82M-
EBITDA$ 115.70M$ 75.32M$ -38.05M$ -48.12M-
Net Income Common Stockholders$ 8.69M$ 81.24M$ -33.21M$ -45.30M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 532.18M$ 562.07M$ 477.52M$ 350.39M$ 379.17M
Total Assets$ 818.36M$ 790.35M$ 684.03M$ 531.85M$ 558.45M
Total Debt$ 8.09M$ 8.32M$ 8.54M$ 8.76M$ 8.93M
Net Debt$ -524.08M$ -553.75M$ -468.97M$ -341.63M$ -370.24M
Total Liabilities$ 39.71M$ 34.40M$ 30.91M$ 42.28M$ 36.22M
Stockholders Equity$ 778.64M$ 755.95M$ 653.08M$ 489.57M$ 522.23M
Cash Flow-
Free Cash Flow$ -9.08M$ 76.99M$ -33.21M$ -31.54M-
Operating Cash Flow$ -7.23M$ -21.23M$ -33.21M$ -26.16M-
Investing Cash Flow$ -10.16M$ 105.19M-$ 3.56M-
Financing Cash Flow$ 2.62M$ 13.39M-$ 1.47M-
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis